Chemed Corp
F:CXM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chemed Corp
F:CXM
|
US |
|
British Land Company PLC
F:BLDA
|
UK |
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
Thomson Medical Group Ltd
SGX:A50
|
SG |
|
CareRay Digital Medical Technology Co Ltd
SSE:688607
|
CN |
|
FG Nexus Inc
F:LU5
|
US |
|
Matsui Securities Co Ltd
OTC:MTSEF
|
JP |
|
I
|
IP Strategy Holdings Inc
NASDAQ:IPST
|
US |
|
F
|
Focus Minerals Ltd
XMUN:FZA
|
AU |
|
I
|
Invenia Co Ltd
KOSDAQ:079950
|
KR |
Intrinsic Value
Is CXM undervalued or overvalued?
See the intrinsic value estimate for 
Chemed Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CXM looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with CXM’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Chemed Does
Chemed Corp is a holding company with two very different businesses: VITAS, which provides hospice care for patients with terminal illnesses, and Roto-Rooter, which provides plumbing, drain cleaning, and related repair services. In simple terms, one side of the company helps people near the end of life, and the other helps homes and businesses fix urgent water and sewer problems.
- Headquarters
- United States of America US
- Employees
- 15 811
- IPO date
- May 27, 1971
Chemed has no economic moat
Chemed Corp lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisLatest Earnings Call
- EPS
- $5.52
- Expected
- $5.12
- Surprise
- +7.8%
- Stock, day of the call
- +1.4%
Revenue & Expenses Breakdown
Chemed Corp
Earnings Waterfall
Chemed Corp
The intrinsic value for Chemed Corp (CXM) under the Base Case is hidden EUR.
Compared with the current market price of 452 EUR, the stock appears hidden.